Tumor cells activate the RIPK3-PGE2 circuit, which significantly promote the synthesis of PGE2 in PMN-MDSCs, ultimately enhancing the immunosuppressive function of PMN-MDSCs. The gene discussed is RIPK3; the disease is neoplasm.